Determining the recommended dose of pacritinib: Results from the PAC203 dose-finding trial in advanced myelofibrosis

  1. Gerds, A.T.
  2. Savona, M.R.
  3. Scott, B.L.
  4. Talpaz, M.
  5. Egyed, M.
  6. Harrison, C.N.
  7. Yacoub, A.
  8. Vannucchi, A.
  9. Mead, A.J.
  10. Kiladjian, J.-J.
  11. O'Sullivan, J.
  12. García-Gutiérrez, V.
  13. Bose, P.
  14. Rampal, R.K.
  15. Miller, C.B.
  16. Palmer, J.
  17. Oh, S.T.
  18. Buckley, S.A.
  19. Mould, D.R.
  20. Ito, K.
  21. Tyavanagimatt, S.
  22. Smith, J.A.
  23. Roman-Torres, K.
  24. Devineni, S.
  25. Craig, A.R.
  26. Mascarenhas, J.O.
  27. Erakutsi egile guztiak +
Aldizkaria:
Blood Advances

ISSN: 2473-9537,  2473-9529

Argitalpen urtea: 2020

Alea: 4

Zenbakia: 22

Orrialdeak: 5825-5835

Mota: Artikulua

DOI: 10.1182/BLOODADVANCES.2020003314 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus